Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
|---|---|---|---|---|---|---|---|---|---|
40 | 19/12/2019 15:12:38 | Male | hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia | rifaximin | 0.55 | Oral | BD | 7 | aspiration pneumonia |
40 | 19/12/2019 15:13:54 | Male | hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia | cefixime | 0.2 | Oral | BD | 7 | aspiration pneumonia |
40 | 19/12/2019 15:15:09 | Male | hyponetrimia, hcv(+), hepatic encephalopathy, aspiration pneumonia | metronidazole | 0.25 | Oral | TDS | 7 | aspiration pneumonia |
59 | 19/12/2019 16:10:39 | Male | right sided hemoporesis territory cerebral infarct, hcv, ospiration pneumonia | metronidazole | 0.75 | IV | TDS | 7 | aspiration pneumonia |
42 | 19/12/2019 16:11:42 | Male | left sided pulmonary tb | ceftriaxone | 1 | IV | BD | 6 | aspiration pneumonia |
30 | 19/12/2019 16:26:46 | Male | asthma | ceftazidine | 1 | IV | TDS | 3 | asthma |
30 | 19/12/2019 15:50:30 | Male | atypical pneumonia, mycoplasma?, itp, left sided pleural effusion | cefoperazone | 1 | IV | BD | 10 | atypical pneumonia |
30 | 19/12/2019 15:52:41 | Male | atypical pneumonia, mycoplasma?, itp, left sided pleural effusion | levofloxacin | 0.5 | IV | OD | 10 | atypical pneumonia |
30 | 19/12/2019 15:55:06 | Male | atypical pneumonia, mycoplasma?, itp, left sided pleural effusion | co-amoxiclav | 1.2 | IV | TDS | 1 | atypical pneumonia |
30 | 19/12/2019 15:57:12 | Male | atypical pneumonia, mycoplasma?, itp, left sided pleural effusion | clarithromycin | 0.5 | Oral | BD | 8 | atypical pneumonia |
34 | 19/12/2019 16:13:24 | Female | aud | ceftriaxone | 1 | IV | BD | 1 | aud |
29 | 19/12/2019 16:14:25 | Female | avi, sle | cefixime | 0.2 | Oral | BD | 6 | avi |
29 | 19/12/2019 16:14:57 | Female | avi, sle | ceftriaxone | 1 | IV | BD | 8 | avi |
48 | 19/12/2019 15:42:45 | Female | pancytopencia, aki, rvi, b,c coinfection | cefoperazone | 1 | IV | BD | 5 | b |
48 | 19/12/2019 15:44:20 | Female | pancytopenia, aki, rvi, b,c coinfection | septrin | 0.96 | Oral | OD | 3 | b |
53 | 19/12/2019 14:48:01 | Male | b(+), col, gastritis | ceftriaxone | 1 | IV | BD | 1 | b |
87 | 19/12/2019 16:35:25 | Female | pad(lt u.l), be amputation,/post op, akt | ceftriaxone | 1 | IV | BD | 1 | be amputation |
31 | 19/12/2019 14:26:26 | Female | rvi stage 4, art noise, hepatitis, bone marrow depression | septrin | 0.96 | Oral | OD | 1 | bone marrow depression |
31 | 19/12/2019 14:28:37 | Female | rvi stage 4, art noise, hepatitis, bone marrow depression | ceftriaxone | 1 | IV | BD | 5 | bone marrow depression |
31 | 19/12/2019 14:30:33 | Female | rvi, stage4, art noise, hepatitis, bone marrow depression | cefipime | 1 | IV | BD | 4 | bone marrow depression |
49 | 19/12/2019 14:39:20 | Female | bppv, type2 DM, postural hypertension | ceftriaxone | 1 | IV | BD | 1 | bppv |
49 | 19/12/2019 14:40:19 | Female | bppv, type2 DM, postural hypertension | cefixime | 1 | Oral | BD | 5 | bppv |
50 | 19/12/2019 16:04:49 | Female | bronchial asthma | co-amoxiclav | 1.2 | IV | TDS | 7 | asthma |
48 | 19/12/2019 15:42:45 | Female | pancytopencia, aki, rvi, b,c coinfection | cefoperazone | 1 | IV | BD | 5 | c coinfection |
48 | 19/12/2019 15:44:20 | Female | pancytopenia, aki, rvi, b,c coinfection | septrin | 0.96 | Oral | OD | 3 | c coinfection |
70 | 19/12/2019 14:04:55 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftriaxone | 1 | IV | BD | 2 | ca buffalo mucosa |
70 | 19/12/2019 14:05:42 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | amikacin | 0.5 | IV | BD | 8 | ca buffalo mucosa |
70 | 19/12/2019 14:06:17 | Female | neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm | ceftazidime | 2 | IV | TDS | 2 | ca buffalo mucosa |
61 | 19/12/2019 15:37:15 | Male | ca lung, lung abscess | co-amoxiclav | 1.2 | IV | TDS | 3 | ca lung |
61 | 19/12/2019 15:38:32 | Male | ca lung, lung abscess | co-amoxiclav | 0.625 | Oral | TDS | 3 | ca lung |
58 | 19/12/2019 15:38:41 | Female | cap, type 2 dm | ceftriaxone | 1 | IV | BD | 5 | cap |
58 | 19/12/2019 15:39:39 | Female | cap, type 2 dm | metronidazole | 0.75 | IV | TDS | 5 | cap |
58 | 19/12/2019 15:40:21 | Female | cap, type 2 dm | cefixime | 0.2 | Oral | BD | 5 | cap |
58 | 19/12/2019 15:40:30 | Female | chronic cardiac failure, community aquired pneumonia, IHD | ceftriaxone | 1 | IV | BD | 1 | cap |
58 | 19/12/2019 15:43:01 | Female | chronic cardiac failure, community aquired pneumonia, IHD | coamoxiclav | 1.2 | IV | TDS | 5 | cap |
69 | 19/12/2019 14:04:40 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | metronidazole | 0.75 | IV | TDS | 5 | cap |
69 | 19/12/2019 14:08:30 | Female | gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg | cefipime | 1 | IV | BD | 1 | cap |
71 | 19/12/2019 16:32:20 | Female | cap, copd, drug inducwd cushing syndrome | co-amoxiclav | 1.2 | IV | TDS | 5 | cap |
71 | 19/12/2019 17:26:59 | Female | cap, copd, drug inducwd cushing syndrome | ceftriaxone | 2 | IV | BD | 2 | cap |
71 | 19/12/2019 17:27:51 | Female | cap, copd, drug inducwd cushing syndrome | clarithromycin | 0.5 | Oral | BD | 5 | cap |
54 | 19/12/2019 14:54:10 | Male | cap, h1n1(+) | cefoperazone | 1 | IV | BD | 14 | cap |
54 | 19/12/2019 14:55:25 | Male | cap, h1n1(+) | cefixime | 0.2 | Oral | BD | 7 | cap |
54 | 19/12/2019 14:56:33 | Male | cap, h1n1(+) | clarithromycin | 0.5 | Oral | BD | 5 | cap |
36 | 19/12/2019 15:57:27 | Male | he grade 3, cap | levofloxacin | 0.5 | IV | OD | 4 | cap |
36 | 19/12/2019 15:59:01 | Male | he grade 3, cap | co-amoxiclav | 1.2 | IV | TDS | 1 | cap |
76 | 19/12/2019 14:22:00 | Male | chest infection, cardiogenic shock | ceftriaxone | 1 | IV | OD | 1 | cardiogenic shock |
78 | 19/12/2019 14:00:59 | Male | copd, chest infection, cardiogenic shock | co-amoxiclav | 1.2 | IV | TDS | 1 | cardiogenic shock |
85 | 19/12/2019 14:41:49 | Female | ccf, hypertension, ida, ckd(stage 5), ?icm, | ceftriaxone | 1 | IV | BD | 7 | ccf |
65 | 19/12/2019 16:22:50 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 1 | IV | TDS | 1 | ccf |
65 | 19/12/2019 16:24:34 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 0.625 | Oral | TDS | 2 | ccf |
65 | 19/12/2019 16:25:18 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | clarithromycin | 0.5 | Oral | BD | 4 | ccf |
65 | 19/12/2019 16:25:52 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | ceftriaxone | 1 | IV | BD | 2 | ccf |
60 | 19/12/2019 14:31:42 | Female | heart failure, hcv, col, ihd, ccf, chest infection | co-amoxiclav | 1.2 | IV | TDS | 1 | ccf |
60 | 19/12/2019 14:33:33 | Female | heart failure, hcv, col, ihd, ccf, chest infection | co-amoxiclav | 0.625 | Oral | OD | 5 | ccf |
52 | 19/12/2019 14:37:18 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | septrin | 0.96 | Oral | OD | 1 | ccf |
52 | 19/12/2019 14:38:22 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | coamoxiclav | 0.6 | IV | OD | 5 | ccf |
52 | 19/12/2019 14:39:09 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | co-amoxiclav | 1.2 | IV | BD | 2 | ccf |
85 | 19/12/2019 14:41:49 | Female | ccf, hypertension, ida, ckd(stage 5), ?icm, | ceftriaxone | 1 | IV | BD | 7 | ccf |
16 | 19/12/2019 13:58:05 | Male | centepede bite | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 5 | centepede bite |
70 | 19/12/2019 14:53:11 | Male | septic shock, miliary tb, cerebral infarct, herpes encephalitis | meropenem | 0.5 | IV | BD | 2 | cerebral infarct |
70 | 19/12/2019 14:54:47 | Male | septic shock, miliary tb, cerebral infarct, herpes encephalitis | septrin | 0.48 | Oral | OD | 1 | cerebral infarct |
37 | 19/12/2019 18:20:14 | Male | col,koch's lung, chest infestion, chronic pancreatitis, lumbar spondylosis | co-amoxiclav | 1.2 | IV | TDS | 6 | cheat infection |
36 | 19/12/2019 18:18:18 | Male | col,koch's lung, chest infestion, chronic pancreatitis, lumbar spondylosis | amikacin | 0.5 | IV | BD | 6 | chest indection |
63 | 19/12/2019 14:46:07 | Male | acute copd, chest infection | ceftazidime | 1 | IV | TDS | 4 | chest infection |
63 | 19/12/2019 14:47:41 | Male | acute copd, chest infection | clarithromycin | 1 | Oral | BD | 1 | chest infection |
63 | 19/12/2019 14:48:52 | Male | acute copd, chest infection | cefixime | 1 | Oral | BD | 7 | chest infection |
64 | 19/12/2019 14:42:05 | Female | acute pulmonary edema, ihd, uti, type 2 dm, chest infection | gentamicin | 0.8 | IV | BD | 6 | chest infection |
64 | 19/12/2019 14:42:34 | Female | acute pulmonary edema, ihd, uti, type 2 dm, chest infection | ceftriaxone | 1 | IV | BD | 5 | chest infection |
51 | 19/12/2019 14:03:01 | Female | acute sever asthma, chest infection | co-amoxiclav | 0.625 | Oral | TDS | 5 | chest infection |
53 | 19/12/2019 16:16:27 | Female | copd, chest infection, ihd, hypertension, newly dx dm | co-amoxiclav | 1.2 | IV | TDS | 3 | chest infection |
53 | 19/12/2019 16:17:09 | Female | copd, chest infection, ihd, hypertension, newly dx dm | ceftriaxone | 1 | IV | BD | 2 | chest infection |
53 | 19/12/2019 16:18:06 | Female | copd, chest infection, ihd, hypertension, newly dx dm | levofloxacin | 0.5 | Oral | OD | 7 | chest infection |
65 | 19/12/2019 16:22:50 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 1 | IV | TDS | 1 | chest infection |
65 | 19/12/2019 16:24:34 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 0.625 | Oral | TDS | 2 | chest infection |
65 | 19/12/2019 16:25:18 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | clarithromycin | 0.5 | Oral | BD | 4 | chest infection |
65 | 19/12/2019 16:25:52 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | ceftriaxone | 1 | IV | BD | 2 | chest infection |
19 | 19/12/2019 18:23:32 | Female | chest infectio, pid | ceftriaxone | 1 | IV | BD | 1 | chest infection |
52 | 19/12/2019 17:31:34 | Male | chest infection, old stroke, af, ischaemic ihd, type2 dm, newly dx rvi | amoxicillin+flucloxacillin | 0.5 | IV | QID | 1 | chest infection |
20 | 19/12/2019 15:20:29 | Male | chest infection, retro (+) | ceftriaxone | 1 | IV | BD | 1 | chest infection |
20 | 19/12/2019 15:22:05 | Male | chest infection, retro(+) | septrin | 0.06 | Oral | OD | 1 | chest infection |
76 | 19/12/2019 15:48:31 | Female | ccf,chest infection, af ē rvr | co-amoxiclav | 1.2 | IV | TDS | 1 | chest infection |
76 | 19/12/2019 15:49:42 | Female | ccf,chest infection, af ē rvr | cefipime | 1 | IV | BD | 1 | chest infection |
76 | 19/12/2019 15:50:24 | Female | ccf,chest infection, af ē rvr | levofloxacin | 1 | IV | BD | 1 | chest infection |
76 | 19/12/2019 15:52:54 | Female | ccf,chest infection, af ē rvr | clarithromycin | 0.5 | Oral | BD | 1 | chest infection |
80 | 19/12/2019 15:58:41 | Male | acute exacerbation of copd | co-amoxiclav | 1.2 | IV | TDS | 1 | chest infection |
60 | 19/12/2019 16:00:34 | Male | ccf with hypertension, dm, chest infection | ceftriaxone | 1 | IV | BD | 7 | chest infection |
71 | 19/12/2019 16:00:36 | Female | copd, chest infection | co-amoxiclav | 1.2 | IV | TDS | 4 | chest infection |
75 | 19/12/2019 16:02:46 | Male | ckd, generalized edema, ihd, hypertension, chest infection (right upper zone) | ceftriaxone | 1 | IV | OD | 5 | chest infection |
82 | 19/12/2019 16:02:51 | Male | chest infection, copd, icm(ef) 29%, type 2 dm | ceftazidime | 1 | IV | TDS | 1 | chest infection |
82 | 19/12/2019 16:04:05 | Male | chest infection, copd, icm(ef) 29%, type 2 dm | ceftazidime | 1 | IV | BD | 1 | chest infection |
82 | 19/12/2019 16:05:20 | Male | chest infection, copd, icm(ef) 29%, type 2 dm | cefixime | 0.2 | Oral | BD | 5 | chest infection |
77 | 19/12/2019 16:05:57 | Female | copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved) | ceftriaxone | 1 | IV | TDS | 1 | chest infection |
77 | 19/12/2019 16:06:54 | Female | copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved) | co-amoxiclav | 1.2 | IV | TDS | 1 | chest infection |
77 | 19/12/2019 16:07:36 | Female | copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved) | co-amoxiclav | 0.625 | Oral | TDS | 10 | chest infection |
77 | 19/12/2019 16:08:19 | Female | copd, chest infection, hypertension, newly dx dm, t2 resp:failure(resolved) | clarithromycin | 0.5 | Oral | BD | 10 | chest infection |
57 | 19/12/2019 16:12:27 | Male | col, massive ascities, chest infection | ceftriaxone | 1 | IV | BD | 3 | chest infection |
51 | 19/12/2019 16:13:39 | Male | copd, chest infection, ihd, koch's lung, newly dx dm | ceftazidine | 1 | IV | TDS | 8 | chest infection |
51 | 19/12/2019 16:14:21 | Male | copd, chest infection, ihd, koch's lung, newly dx dm | linezolid | 0.6 | Oral | BD | 7 | chest infection |
20 | 19/12/2019 16:22:12 | Male | chest infection, u/l inflammatory arthropathy on steroid, hepatitis | ceftriaxone | 1 | IV | BD | 9 | chest infection |
19 | 19/12/2019 16:33:13 | Female | chest infection, pid | metronidazole | 0.75 | IV | TDS | 3 | chest infection |